DXCM
DexCom, Inc. · Healthcare
Director Mark G Foletta sold $331K of DexCom, Inc.
Sold$330,640
$82.66Price
4,000Shares
−8%Stake
What DXCM did after the filing
- The stock from Wed, Aug 5 open, $86.47
- +3.3%
- S&P 500, same days
- −1.8%
Measured over 30 trading days, to the Sep 18 close.
Traded Fri, Jul 31. Filed Tue, Aug 4, 4:38 PM ET, after the close. Returns use the Aug 5 open and the Sep 18 close. Not investment advice.